메뉴 건너뛰기




Volumn 10, Issue 8, 2009, Pages 1273-1289

Pharmacotherapy of vasculitis

Author keywords

ANCA; Azathioprine; Cyclophosphamide; Giant cell arteritis; Methotrexate; Microscopic polyangiitis; Prednisolone; Systemic vasculitis; Takayasu's arteritis; Wegener's granulomatosis

Indexed keywords

15 DEOXYSPERGUALIN; ABATACEPT; ABCIXIMAB; ACETYLSALICYLIC ACID; ALPHA INTERFERON; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETANERCEPT; GLUCOCORTICOID; HEPARIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN E ANTIBODY; INFLIXIMAB; LAMIVUDINE; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMALIZUMAB; PEGINTERFERON ALPHA2B; PREDNISOLONE; RIBAVIRIN; RITUXIMAB; THYMOCYTE ANTIBODY; UNINDEXED DRUG; VIDARABINE;

EID: 67649716645     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560902946401     Document Type: Review
Times cited : (16)

References (126)
  • 1
    • 0028158243 scopus 로고
    • Nomenclature of systemic vasculitides. Proposal of an international consensus conference
    • A useful an important starting point for defining many different types of vasculitis
    • Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192 • A useful an important starting point for defining many different types of vasculitis.
    • (1994) Arthritis Rheum , vol.37 , pp. 187-192
    • Jennette, J.C.1    Falk, R.J.2    Andrassy, K.3
  • 2
    • 61449178959 scopus 로고    scopus 로고
    • EULAR Recommendations for the management of large vessel vasculitis
    • An evidence-based review of management of systemic vasculitis affecting large vessels
    • Mukhtyar C, Guillevin L, Cid MC, et al. EULAR Recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009;68:318-323 •• An evidence-based review of management of systemic vasculitis affecting large vessels.
    • (2009) Ann Rheum Dis , vol.68 , pp. 318-323
    • Mukhtyar, C.1    Guillevin, L.2    Cid, M.C.3
  • 3
    • 61449238213 scopus 로고    scopus 로고
    • EULAR Recommendations for the management of primary small and medium vessel vasculitis
    • An evidence-based review of management of systemic vasculitis affecting medium and small vessels
    • Mukhtyar C, Guillevin L, Cid MC, et al. EULAR Recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 2009;68:310-317 •• An evidence-based review of management of systemic vasculitis affecting medium and small vessels.
    • (2009) Ann Rheum Dis , vol.68 , pp. 310-317
    • Mukhtyar, C.1    Guillevin, L.2    Cid, M.C.3
  • 4
    • 39749124664 scopus 로고    scopus 로고
    • BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis
    • BSR and BHPR Standards, Guidelines and Audit Working Group. (Oxford)
    • Lapraik C, Watts R, Bacon P, et al. BSR and BHPR Standards, Guidelines and Audit Working Group. BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) 2007;46:1615-1616
    • (2007) Rheumatology , vol.46 , pp. 1615-1616
    • Lapraik, C.1    Watts, R.2    Bacon, P.3
  • 7
    • 0001179656 scopus 로고
    • Treatment of temporal arteritis with adrenal corticosteroids. Results in 55 cases in which lesions was proved at biopsy
    • Birkhead NC, Wagereor HP, Shick RM. Treatment of temporal arteritis with adrenal corticosteroids. Results in 55 cases in which lesions was proved at biopsy. J Am Med Assoc 1957;163:821-827
    • (1957) J Am Med Assoc , vol.163 , pp. 821-827
    • Birkhead, N.C.1    Wagereor, H.P.2    Shick, R.M.3
  • 8
    • 0142063451 scopus 로고    scopus 로고
    • Glucocorticoid therapy in GCA: Duration and adverse outcomes
    • Proven A, Gabriel SE. Glucocorticoid therapy in GCA: duration and adverse outcomes. Arthritis Rheum 2003;49:703-708
    • (2003) Arthritis Rheum , vol.49 , pp. 703-708
    • Proven, A.1    Gabriel, S.E.2
  • 9
  • 12
    • 0347386450 scopus 로고    scopus 로고
    • Experience with infliximab as monotherapy for giant cell arteritis
    • Andonopoulos AP, Meimaris N, Daoussis D, et al. Experience with infliximab as monotherapy for giant cell arteritis. Ann Rheum Dis 2003;62:1116
    • (2003) Ann Rheum Dis , vol.62 , pp. 1116
    • Andonopoulos, A.P.1    Meimaris, N.2    Daoussis, D.3
  • 13
    • 33750337784 scopus 로고    scopus 로고
    • Antiplatelet and anticoagulant therapy I patients with GCA
    • Lee MS, Smith SD, Gala A, Hoffman GS. Antiplatelet and anticoagulant therapy I patients with GCA. Arthirits Rheum 2006;54:3306-3309
    • (2006) Arthirits Rheum , vol.54 , pp. 3306-3309
    • Lee, M.S.1    Smith, S.D.2    Gala, A.3    Hoffman, G.S.4
  • 15
    • 52049107418 scopus 로고    scopus 로고
    • Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis
    • Narváez J, Bernad B, Gómez-Vaquero C, et al. Impact of antiplatelet therapy in the development of severe ischemic complications and in the outcome of patients with giant cell arteritis. Clin Exp Rheumatol 2008;26:S57-62
    • (2008) Clin Exp Rheumatol , vol.26
    • Narváez, J.1    Bernad, B.2    Gómez-Vaquero, C.3
  • 16
  • 17
    • 0016500042 scopus 로고
    • Daily and alternate day corticosteroid regimens in treatment of GCA: Comparison in a prospective study
    • Hunder GG, Sheps SG, Allen GL, Joyce JW. Daily and alternate day corticosteroid regimens in treatment of GCA: comparison in a prospective study. Ann Intern Med 1975;82:613-618
    • (1975) Ann Intern Med , vol.82 , pp. 613-618
    • Hunder, G.G.1    Sheps, S.G.2    Allen, G.L.3    Joyce, J.W.4
  • 19
    • 0036090211 scopus 로고    scopus 로고
    • International Network for the Study of Systemic Vasculitides A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis
    • Hoffman GS, Cid MC, Hellmann DB, et al. International Network for the Study of Systemic Vasculitides A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum 2002;46:1309-1318
    • (2002) Arthritis Rheum , vol.46 , pp. 1309-1318
    • Hoffman, G.S.1    Cid, M.C.2    Hellmann, D.B.3
  • 22
    • 0022578244 scopus 로고
    • Azathioprine in GCA - A double blind study
    • De Silva M, Hazleman BL. Azathioprine in GCA - A double blind study. Ann Rheum Dis 1986;45:136-138
    • (1986) Ann Rheum Dis , vol.45 , pp. 136-138
    • De Silva, M.1    Hazleman, B.L.2
  • 23
    • 34248351219 scopus 로고    scopus 로고
    • Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: A randomized trial
    • Infliximab-GCA Study Group
    • Hoffman GS, Cid MC, Rendt-Zagar KE, et al. Infliximab-GCA Study Group. Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med 2007;146:621-630
    • (2007) Ann Intern Med , vol.146 , pp. 621-630
    • Hoffman, G.S.1    Cid, M.C.2    Rendt-Zagar, K.E.3
  • 25
    • 0035674050 scopus 로고    scopus 로고
    • Treatment of longstanding active GCA with infliximab:report of four cases
    • Cantini F, Niccoli L, Salvarani C et al. Treatment of longstanding active GCA with infliximab:report of four cases Arthritis Rheum 2001;44:2933-2935
    • (2001) Arthritis Rheum , vol.44 , pp. 2933-2935
    • Cantini, F.1    Niccoli, L.2    Salvarani, C.3
  • 27
  • 28
    • 21344460261 scopus 로고    scopus 로고
    • Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis
    • DOI 10.1136/ard.2005.036533
    • Bhatia A, Ell PJ, Edwards JC. Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis. Ann Rheum Dis 2005;64:1099-1100 (Pubitemid 40909539)
    • (2005) Annals of the Rheumatic Diseases , vol.64 , Issue.7 , pp. 1099-1100
    • Bhatia, A.1    Ell, P.J.2    Edwards, J.C.W.3
  • 30
    • 0041528396 scopus 로고    scopus 로고
    • Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis
    • Valsakumar AK, Valappil UC, Jorapur V, et al. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis. Rheumatol 2003;30:1793-1798 (Pubitemid 36962457)
    • (2003) Journal of Rheumatology , vol.30 , Issue.8 , pp. 1793-1798
    • Valsakumar, A.K.1    Valappil, U.C.2    Jorapur, V.3    Garg, N.4    Nityanand, S.5    Sinha, N.6
  • 31
    • 3142685997 scopus 로고    scopus 로고
    • Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis
    • DOI 10.1002/art.20300
    • Hoffman GS, Merkel PA, Brasington RD, et al. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 2004;50(7):2296-2304 (Pubitemid 38924409)
    • (2004) Arthritis and Rheumatism , vol.50 , Issue.7 , pp. 2296-2304
    • Hoffman, G.S.1    Merkel, P.A.2    Brasington, R.D.3    Lenschow, D.J.4    Liang, P.5
  • 32
    • 54349085648 scopus 로고    scopus 로고
    • Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: Long-term follow-up
    • Epub 2008 Aug 3
    • Molloy ES, Langford CA, Clark TM, et al. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 2008;67(11):1567-1569 [Epub 2008 Aug 3]
    • (2008) Ann Rheum Dis , vol.67 , Issue.11 , pp. 1567-1569
    • Molloy, E.S.1    Langford, C.A.2    Clark, T.M.3
  • 33
    • 0028897177 scopus 로고
    • Treatment of resistant Takayasu's arteritis
    • Hoffman GS. Treatment of resistant Takayasu's arteritis. Rheum Dis Clin North Am 1995;21:73-80
    • (1995) Rheum Dis Clin North Am , vol.21 , pp. 73-80
    • Hoffman, G.S.1
  • 34
    • 0000772321 scopus 로고
    • The kidney in polyarteritis nodosa
    • Davson J, Ball J, Platt R. The kidney in polyarteritis nodosa. QJM 1948;17:175-202
    • (1948) QJM , vol.17 , pp. 175-202
    • Davson, J.1    Ball, J.2    Platt, R.3
  • 35
    • 0025881485 scopus 로고
    • Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients
    • The Cooperative Study Group for Polyarteritis Nodosa
    • Guillevin L, Jarrousse B, Lok C, et al. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa. J Rheumatol 1991;18:567-574
    • (1991) J Rheumatol , vol.18 , pp. 567-574
    • Guillevin, L.1    Jarrousse, B.2    Lok, C.3
  • 37
    • 12544253745 scopus 로고    scopus 로고
    • Etanercept plus standard therapy for Wegener's granulomatosis
    • Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
    • Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med 2005;352:351-361
    • (2005) N Engl J Med , vol.352 , pp. 351-361
  • 38
    • 45849124232 scopus 로고    scopus 로고
    • British Society for Rheumatology, British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group; British Association of Dermatologists (BAD) BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
    • Chakravarty K, McDonald H, Pullar T, et al. British Society for Rheumatology, British Health Professionals in Rheumatology Standards, Guidelines and Audit Working Group; British Association of Dermatologists (BAD) BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists. Rheumatology 2008;47:924-925
    • (2008) Rheumatology , vol.47 , pp. 924-925
    • Chakravarty, K.1    McDonald, H.2    Pullar, T.3
  • 41
    • 34248526053 scopus 로고    scopus 로고
    • Churg-strauss syndrome with poor-prognosis factors: A prospective multicenter trail comparing glucocorticoids and six and twelve cyclophosphamide pulses in forty-eight patients
    • French Vasculitis Study Group
    • Cohen P, Pagnoux C, Mahr A, et al. French Vasculitis Study Group. Churg-strauss syndrome with poor-prognosis factors: a prospective multicenter trail comparing glucocorticoids and six and twelve cyclophosphamide pulses in forty-eight patients. Arthritis Rheum 2007;57:686-693
    • (2007) Arthritis Rheum , vol.57 , pp. 686-693
    • Cohen, P.1    Pagnoux, C.2    Mahr, A.3
  • 43
    • 22244443649 scopus 로고    scopus 로고
    • Refractory polyarteritis nodosa successfully treated with infliximab
    • Al-Bishri J, le Riche N, Pope JE. Refractory polyarteritis nodosa successfully treated with infliximab. J Rheumatol 2005;32:1371-1373 (Pubitemid 40995399)
    • (2005) Journal of Rheumatology , vol.32 , Issue.7 , pp. 1371-1373
    • Al-Bishri, J.1    Le Riche, N.2    Pope, J.E.3
  • 44
    • 33746351498 scopus 로고    scopus 로고
    • Infliximab in a child with therapy-resistant systemic vasculitis
    • de Kort SW, van Rossum MA, ten Cate R. Infliximab in a child with therapy-resistant systemic vasculitis. Clin Rheumatol 2006;25:769-771
    • (2006) Clin Rheumatol , vol.25 , pp. 769-771
    • De Kort, S.W.1    Van Rossum, M.A.2    Ten Cate, R.3
  • 45
    • 33744782622 scopus 로고    scopus 로고
    • A new treatment for polyarteritis nodosa
    • DOI 10.1093/ndt/gfk082
    • Wu K, Throssell D. A new treatment for polyarteritis nodosa. Nephrol Dial Transplant 2006;21:2044 (Pubitemid 43834650)
    • (2006) Nephrology Dialysis Transplantation , vol.21 , Issue.6 , pp. 1710-1712
    • Wu, K.1    Throssell, D.2
  • 47
    • 0035742709 scopus 로고    scopus 로고
    • Transient and partial effect of high-dose intravenous immunoglobulin in polyarteritis nodosa
    • DOI 10.1159/000051741
    • Kroiss M, Hohenleutner U, Gruss C, et al. Transient and partial effect of high-dose intravenous immunoglobulin in polyarteritis nodosa. Dermatology 2001;203:188-189 (Pubitemid 34701586)
    • (2001) Dermatology , vol.203 , Issue.2 , pp. 188-189
    • Kroiss, M.1    Hohenleutner, U.2    Gruss, C.3    Glaessl, A.4    Landthaler, M.5    Stolz, W.6
  • 49
    • 0033952713 scopus 로고    scopus 로고
    • Low-dose methotrexate controls a severe form of polyarteritis nodosa
    • Boehm I, Bauer R. Low-dose methotrexate controls a severe form of polyarteritis nodosa Arch. Dermatol 2000;136:167-169 (Pubitemid 30090753)
    • (2000) Archives of Dermatology , vol.136 , Issue.2 , pp. 167-169
    • Boehm, I.1    Bauer, R.2
  • 50
    • 0027998762 scopus 로고
    • ERFOLGREICHE BEHANDLUNG EINER PANARTERIITIS NODOSA MIT METHOTREXAT LOW-DOSE-THERAPIE
    • DOI 10.1007/s001050050108
    • Brody M, Böhm I, Biwer E, Bauer R. Successful treatment of panarteritis nodosa with low-dose methotrexate therapy. Hautarzt 1994;45:476-479 (Pubitemid 24232643)
    • (1994) Hautarzt , vol.45 , Issue.7 , pp. 476-479
    • Brody, M.1    Bohm, I.2    Biwer, E.3    Bauer, R.4
  • 51
    • 0025940046 scopus 로고
    • Cutaneous polyarteritis nodosa and Behçet's disease
    • Jorizzo JL, White WL, Wise CM, et al. cutaneous polyarteritis nodosa and Behçet's disease. J Am Acad Dermatol 1991;24:973-978
    • (1991) J Am Acad Dermatol , vol.24 , pp. 973-978
    • Jorizzo, J.L.1    White, W.L.2    Wise, C.M.3
  • 52
    • 0019278060 scopus 로고
    • Combined therapy with methotrexate and prednisone in polyarteritis nodosa
    • Tannenbaum H. Combined therapy with methotrexate and prednisone in polyarteritis nodosa. Can Med Assoc J 1980;123:893-894 (Pubitemid 11146205)
    • (1980) Canadian Medical Association Journal , vol.123 , Issue.9 , pp. 893-894
    • Tannenbaum, H.1
  • 54
    • 67649231722 scopus 로고    scopus 로고
    • Drug targets in hepatits B virus infection
    • Stein LL, Loomba R. Drug targets in hepatits B virus infection. Infect Disord Drug Targets 2009;9(2):105-116
    • (2009) Infect Disord Drug Targets , vol.9 , Issue.2 , pp. 105-116
    • Stein, L.L.1    Loomba, R.2
  • 55
    • 0018770498 scopus 로고
    • Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange
    • Lockwood C, Worledge S, Nicholas A, et al. Reversal of impaired splenic function in patients with nephritis or vaculitis (or both) by plasma exchange. N Engl J Med 1979;300:524-530 (Pubitemid 9167826)
    • (1979) New England Journal of Medicine , vol.300 , Issue.10 , pp. 524-530
    • Lockwood, C.M.1    Worlledge, S.2    Nicholas, A.3
  • 56
    • 24044478502 scopus 로고    scopus 로고
    • Hepatitis B virus-associated polyarteritis nodosa: Clinical characteristics, outcome, and impact of treatment in 115 patients
    • DOI 10.1097/01.md.0000180792.80212.5e
    • Guillevin L, Mahr A, Callard P, et al. French Vasculitis Study Group Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine 2005;84:313-322 (Pubitemid 41368484)
    • (2005) Medicine , vol.84 , Issue.5 , pp. 313-322
    • Guillevin, L.1    Mahr, A.2    Callard, P.3    Godmer, P.4    Pagnoux, C.5    Leray, E.6    Cohen, P.7
  • 57
    • 0025807181 scopus 로고
    • Nationwide survey of Kawasaki disease and acute rheumatic fever
    • Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr 1991;119:279-282
    • (1991) J Pediatr , vol.119 , pp. 279-282
    • Taubert, K.A.1    Rowley, A.H.2    Shulman, S.T.3
  • 58
    • 0028863033 scopus 로고
    • The prevention of coronary artery aneurysm in Kawasaki disease: A meta-analysis on the efficacy of aspirin and immunoglobulin treatment
    • Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995;96:1057-1061
    • (1995) Pediatrics , vol.96 , pp. 1057-1061
    • Durongpisitkul, K.1    Gururaj, V.J.2    Park, J.M.3    Martin, C.F.4
  • 59
    • 0021702429 scopus 로고
    • High-dose intravenous gammaglobulin for Kawasaki disease
    • Furusho K, Kamiya T, Nakano H, et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 1984;2:1055-1058 (Pubitemid 15211522)
    • (1984) Lancet , vol.2 , Issue.8411 , pp. 1055-1058
    • Furusho, K.1    Kamiya, T.2    Nakano, H.3
  • 60
    • 0022485186 scopus 로고
    • The treatment of Kawasaki syndrome with intravenous gamma globulin
    • Newburger JW, Takahashi M, Burns JC, et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 1986;315:341-347 (Pubitemid 16060087)
    • (1986) New England Journal of Medicine , vol.315 , Issue.6 , pp. 341-347
    • Newburger, J.W.1    Takahashi, M.2    Burns, J.C.3
  • 61
    • 0031441688 scopus 로고    scopus 로고
    • Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose
    • DOI 10.1016/S0022-3476(97)70038-6
    • Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 1997;131:888 (Pubitemid 28027615)
    • (1997) Journal of Pediatrics , vol.131 , Issue.6 , pp. 888-893
    • Terai, M.1    Shulman, S.T.2
  • 64
    • 0942297988 scopus 로고    scopus 로고
    • Evaluation of the Efficacy of Treatment of Kawasaki Disease before Day 5 of Illness
    • DOI 10.1007/s00246-003-0558-4
    • Fong NC, Hui YW, Li CK, Chiu MC. Evaluation of the efficacy of treatment of Kawasaki disease before day 5 of illness. Pediatr Cardiol 2004;25:31-34 (Pubitemid 38140853)
    • (2004) Pediatric Cardiology , vol.25 , Issue.1 , pp. 31-34
    • Fong, N.C.1    Hui, Y.W.2    Li, C.K.3    Chiu, M.C.4
  • 65
    • 0025935353 scopus 로고
    • Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities
    • Marasini M, Pongiglione G, Gazzolo D, et al. Late intravenous gamma globulin treatment in infants and children with Kawasaki disease and coronary artery abnormalities. Am J Cardiol 1991;68:796-797
    • (1991) Am J Cardiol , vol.68 , pp. 796-797
    • Marasini, M.1    Pongiglione, G.2    Gazzolo, D.3
  • 66
    • 39049175106 scopus 로고    scopus 로고
    • General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
    • Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC)
    • Kroger AT, Atkinson WL, Marcuse EK, Pickering LK. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55(RR-15):1-48
    • (2006) MMWR Recomm Rep , vol.55 , Issue.RR-15 , pp. 1-48
    • Kroger, A.T.1    Atkinson, W.L.2    Marcuse, E.K.3    Pickering, L.K.4
  • 68
    • 0028988292 scopus 로고
    • Kawasaki disease in infants less than one year of age
    • Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr 1995;126:524-529
    • (1995) J Pediatr , vol.126 , pp. 524-529
    • Rosenfeld, E.A.1    Corydon, K.E.2    Shulman, S.T.3
  • 69
    • 8444247048 scopus 로고    scopus 로고
    • Acute management of Kawasaki disease
    • DOI 10.1016/j.ppedcard.2004.08.006, PII S1058981304000281
    • Dummer KB, Newburger JW. Acute management of Kawasaki disease. Prog Pediatr Cardiol 2004;19:129-135 (Pubitemid 39485650)
    • (2004) Progress in Pediatric Cardiology , vol.19 , Issue.2 SPEC.ISS. , pp. 129-135
    • Dummer, K.B.1    Newburger, J.W.2
  • 70
    • 67649686861 scopus 로고    scopus 로고
    • Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: A meta-analysis of 862 children
    • Wooditch AC, Aronoff SC. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. J Pediatr 2006;149:336-341
    • (2006) J Pediatr , vol.149 , pp. 336-341
    • Wooditch, A.C.1    Aronoff, S.C.2
  • 71
    • 33747875063 scopus 로고    scopus 로고
    • A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: Clinical course and coronary artery outcome
    • DOI 10.1016/j.jpeds.2006.05.025, PII S002234760600463X
    • Inoue Y, Okada Y, Shinohara M, et al. A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome. J Pediatr 2006;149:336-341 (Pubitemid 44308435)
    • (2006) Journal of Pediatrics , vol.149 , Issue.3
    • Inoue, Y.1    Okada, Y.2    Shinohara, M.3    Kobayashi, T.4    Kobayashi, T.5    Tomomasa, T.6    Takeuchi, K.7    Morikawa, A.8
  • 72
    • 33846995989 scopus 로고    scopus 로고
    • Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease
    • Pediatric Heart Network Investigators. Pediatric Heart Network Investigators
    • Newburger JW, Sleeper LA, McCrindle BW, et al. Pediatric Heart Network Investigators. Pediatric Heart Network Investigators. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med 2007;356:663-675
    • (2007) N Engl J Med , vol.356 , pp. 663-675
    • Newburger, J.W.1    Sleeper, L.A.2    McCrindle, B.W.3
  • 73
    • 0032411505 scopus 로고    scopus 로고
    • Intravenous gamma-globulin treatment and retreatment in Kawasaki disease
    • US/Canadian Kawasaki Syndrome Study Group
    • Burns JC, Capparelli EV, Brown JA, et al. US/Canadian Kawasaki Syndrome Study Group. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr Infect Dis J 1998;17:1144-1148
    • (1998) Pediatr Infect Dis J , vol.17 , pp. 1144-1148
    • Burns, J.C.1    Capparelli, E.V.2    Brown, J.A.3
  • 76
    • 0036371306 scopus 로고    scopus 로고
    • Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease?
    • Williams RV, Wilke VM, Tani LY, Minich LL. Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease? Pediatrics 2002;109:E4
    • (2002) Pediatrics , vol.109
    • Williams, R.V.1    Wilke, V.M.2    Tani, L.Y.3    Minich, L.L.4
  • 77
    • 18844398919 scopus 로고    scopus 로고
    • Treatment of intravenous immunoglobulin-resistant Kawasaki disease with methotrexate
    • DOI 10.1080/03009740510026328
    • Ahn SY, Kim DS. Treatment of intravenous immunoglobulin-resistant Kawasaki disease with methotrexate. Scand J Rheumatol 2005;34:136-139 (Pubitemid 40694833)
    • (2005) Scandinavian Journal of Rheumatology , vol.34 , Issue.2 , pp. 136-139
    • Ahn, S.-Y.1    Kim, D.S.2
  • 78
    • 44949245186 scopus 로고    scopus 로고
    • Infliximab treatment in refractory Kawasaki syndrome
    • DOI 10.1007/s12098-008-0084-8
    • Girish M, Subramaniam G. Infliximab treatment in refractory Kawasaki syndrome. Indian J Pediatr 2008;75:521-522 (Pubitemid 351814605)
    • (2008) Indian Journal of Pediatrics , vol.75 , Issue.5 , pp. 521-522
    • Girish, M.1    Subramaniam, G.2
  • 79
    • 34247216142 scopus 로고    scopus 로고
    • Incomplete and atypical Kawasaki disease in a young infant: Severe, recalcitrant disease responsive to infliximab
    • DOI 10.1177/0009922806294842
    • O'Connor MJ, Saulsbury FT. Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab. Clin Pediatr (Phila) 2007;46:345-348 (Pubitemid 46609103)
    • (2007) Clinical Pediatrics , vol.46 , Issue.4 , pp. 345-348
    • O'Connor, M.J.1    Saulsbury, F.T.2
  • 81
    • 33746809371 scopus 로고    scopus 로고
    • The effect of TNFalpha blockade in complicated, refractory Kawasaki disease
    • DOI 10.1080/03009740600588228, PII W3747G517N340J14
    • Stenbøg EV, Windelborg B, Hørlyck A, Herlin T. The effect of TNFalpha blockade in complicated, refractory Kawasaki disease. Scand J Rheumatol 2006;35:318-321 (Pubitemid 44181186)
    • (2006) Scandinavian Journal of Rheumatology , vol.35 , Issue.4 , pp. 318-321
    • Stenbog, E.V.1    Windelborg, B.2    Horlyck, A.3    Herlin, T.4
  • 83
    • 17744411736 scopus 로고    scopus 로고
    • Initial intravenous gammaglobulin treatment failure in Kawasaki disease
    • Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000;105:E78
    • (2000) Pediatrics , vol.105
    • Wallace, C.A.1    French, J.W.2    Kahn, S.J.3    Sherry, D.D.4
  • 85
    • 40949086903 scopus 로고    scopus 로고
    • Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin
    • Mori M. Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin. Nippon Rinsho 2008;66:349-354
    • (2008) Nippon Rinsho , vol.66 , pp. 349-354
    • Mori, M.1
  • 86
    • 34548144935 scopus 로고    scopus 로고
    • Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA- associated vasculitis -preliminary center experience
    • 10591
    • Rihová Z, Jancová E, Merta M, et al. Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA- associated vasculitis -preliminary center experience. Prague Med Rep 2004;10591:64-68
    • (2004) Prague Med Rep , pp. 64-68
    • Rihová, Z.1    Jancová, E.2    Merta, M.3
  • 89
    • 0037097601 scopus 로고    scopus 로고
    • High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate
    • Reinhold-Keller E, Fink CO, Herlyn K, et al. High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate. Arthritis Rheum 2002;47:326-332 (Pubitemid 34627702)
    • (2002) Arthritis Care and Research , vol.47 , Issue.3 , pp. 326-332
    • Reinhold-Keller, E.1    Fink, C.O.E.2    Herlyn, K.3    Gross, W.L.4    De Groot, K.5
  • 90
    • 0029946561 scopus 로고    scopus 로고
    • Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis
    • Dutch Co-Trimoxazole Wegener Study Group
    • Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim- sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996;335:16-20
    • (1996) N Engl J Med , vol.335 , pp. 16-20
    • Stegeman, C.A.1    Tervaert, J.W.2    De Jong, P.E.3    Kallenberg, C.G.4
  • 92
    • 0033942210 scopus 로고    scopus 로고
    • Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease. activity
    • Jayne DR, Chapel H, Adu D, et al. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease. activity QJM 2000;93:433-439
    • (2000) QJM , vol.93 , pp. 433-439
    • Jayne, D.R.1    Chapel, H.2    Adu, D.3
  • 93
    • 0029964713 scopus 로고    scopus 로고
    • Intravenous immunoglobulin as sole therapy for systemic vasculitis
    • Jayne DR, Lockwood CM. I ntravenous immunoglobulin as sole therapy for systemic vasculitis. Br J Rheumatol 1996;35(11):1150-1153 (Pubitemid 26397615)
    • (1996) British Journal of Rheumatology , vol.35 , Issue.11 , pp. 1150-1153
    • Jayne, D.R.W.1    Lockwood, C.M.2
  • 97
    • 0037447483 scopus 로고    scopus 로고
    • Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: Extended follow-up and rate of relapse
    • DOI 10.1016/S0002-9343(03)00077-9
    • Langford CA, Talar-Williams C, Barron KS, Sneller MC. Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse. Am J Med 2003;114:463-469 (Pubitemid 36515108)
    • (2003) American Journal of Medicine , vol.114 , Issue.6 , pp. 463-469
    • Langford, C.A.1    Talar-Williams, C.2    Barron, K.S.3    Sneller, M.C.4
  • 99
    • 34447323863 scopus 로고    scopus 로고
    • German network of rheumatic diseases. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis
    • Metzler C, Miehle N, Manger K, et al. German network of rheumatic diseases. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology (Oxford) 2007;46:1087-1091
    • (2007) Rheumatology (Oxford) , vol.46 , pp. 1087-1091
    • Metzler, C.1    Miehle, N.2    Manger, K.3
  • 100
    • 34447302857 scopus 로고    scopus 로고
    • Leflunomide versus methotrexate in Wegener's granulomatosis
    • DOI 10.1093/rheumatology/kem050
    • Jayne D. Leflunomide versus methotrexate in Wegener's granulomatosis. Editorial. Rheumatology 2007;46:1047-1048 (Pubitemid 47050600)
    • (2007) Rheumatology , vol.46 , Issue.7 , pp. 1047-1048
    • Jayne, D.1
  • 101
    • 1842628929 scopus 로고    scopus 로고
    • Mycophenolate Mofetil for Remission Maintenance in the Treatment of Wegener's Granulomatosis
    • Langford CA, Talar-Williams C, Sneller MC. Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis. Arthritis Rheum 2004;51:278-328 (Pubitemid 38468715)
    • (2004) Arthritis Care and Research , vol.51 , Issue.2 , pp. 278-283
    • Langford, C.A.1    Talar-Williams, C.2    Sneller, M.C.3
  • 102
    • 33344473052 scopus 로고    scopus 로고
    • Mycofenolate mofetil in anti-neutrophil associated systemic vasculitis
    • Koulaki M, Jayne DR. Mycofenolate mofetil in anti-neutrophil associated systemic vasculitis. Nephron Clin Pract 2006;102:c100-7
    • (2006) Nephron Clin Pract , vol.102
    • Koulaki, M.1    Jayne, D.R.2
  • 103
    • 58149180323 scopus 로고    scopus 로고
    • Azathioprine or methotrexate maintenance for ANCA-associated vasculitis
    • For the French Vasculitis Study Group
    • Pagnoux C, Mahr A, Hamidou MA, et al. For the French Vasculitis Study Group. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. NEJM 2008;359:2790-2803
    • (2008) NEJM , vol.359 , pp. 2790-2803
    • Pagnoux, C.1    Mahr, A.2    Hamidou, M.A.3
  • 104
    • 0030464106 scopus 로고    scopus 로고
    • Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis: Methotrexate versus trimethoprim/ sulfamethoxazole
    • de Groot K, Reinhold-Keller E, Tatsis E, et al. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis: methotrexate versus trimethoprim/sulfamethoxazole. Arthritis Rheum 1996;39:2052-2061 (Pubitemid 127607906)
    • (1996) Arthritis and Rheumatism , vol.39 , Issue.12 , pp. 2052-2061
    • De Groot, K.1    Reinhold-Keller, E.2    Tatsis, E.3    Paulsen, J.4    Heller, M.5    Nolle, B.6    Gross, W.L.7
  • 105
    • 0033499210 scopus 로고    scopus 로고
    • A staged approach to the treatment of Wegener's granulomatosis: Induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance
    • DOI 10.1002/1529-0131(199912)42:12<2666::AID-ANR24>3.0.CO;2-E
    • Langford CA, Talar-Williams C, Barron KS, Sneller MC. A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance. Arthritis Rheum 1999;42:2666-2673 (Pubitemid 30327189)
    • (1999) Arthritis and Rheumatism , vol.42 , Issue.12 , pp. 2666-2673
    • Langford, C.A.1    Talar-Williams, C.2    Barron, K.S.3    Sneller, M.C.4
  • 108
    • 33750945860 scopus 로고    scopus 로고
    • Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: A long-term followup study
    • DOI 10.1002/art.22168
    • Saadoun D, Resche-Rigon M, Thibault V, et al. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term follow up study. Arthritis Rheum 2006;54:3696-3706 (Pubitemid 44737183)
    • (2006) Arthritis and Rheumatism , vol.54 , Issue.11 , pp. 3696-3706
    • Saadoun, D.1    Resche-Rigon, M.2    Thibault, V.3    Piette, J.-C.4    Cacoub, P.5
  • 109
    • 0023819955 scopus 로고
    • Epidemiology of Schonlein-Henoch purpura
    • Nielsen HE. Epidemiology of Schönlein-Henoch purpura. Acta Paediatr Scand 1988;77:125-131 (Pubitemid 18081556)
    • (1988) Acta Paediatrica Scandinavica , vol.77 , Issue.1 , pp. 125-131
    • Nielsen, H.E.1
  • 112
    • 59649090122 scopus 로고    scopus 로고
    • Prevention and treatment of renal disease in Henoch-Schönlein purpura: A systematic review
    • Chartapisak W, Opastirakul S, Willis N, et al. Prevention and treatment of renal disease in Henoch-Schönlein purpura: a systematic review. Arch Dis Child 2009;94:132-137
    • (2009) Arch Dis Child , vol.94 , pp. 132-137
    • Chartapisak, W.1    Opastirakul, S.2    Willis, N.3
  • 113
    • 0346007910 scopus 로고    scopus 로고
    • Henoch-Schönlein purpura nephritis: Course of disease and efficacy of cyclophosphamide
    • DOI 10.1007/s00467-003-1315-x
    • Tarshish P, Bernstein J, Edelmann CM. Henoch-Schönlein purpura nephritis: course of disease and efficacy of cyclophosphamide. Pediatric Nephrology 2004;19:51-56 (Pubitemid 38088250)
    • (2004) Pediatric Nephrology , vol.19 , Issue.1 , pp. 51-56
    • Tarshish, P.1    Bernstein, J.2    Edelmann Jr., C.M.3
  • 114
    • 12344330217 scopus 로고    scopus 로고
    • Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis
    • DOI 10.1002/art.20718
    • Keogh KA, Wylam ME, Stone JH, Specks U. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2005;52:262-268 (Pubitemid 40129256)
    • (2005) Arthritis and Rheumatism , vol.52 , Issue.1 , pp. 262-268
    • Keogh, K.A.1    Wylam, M.E.2    Stone, J.H.3    Specks, U.4
  • 115
    • 0037073001 scopus 로고    scopus 로고
    • Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients
    • Lamprecht P, Arbach O, Voswinkel J, et al. Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis - Follow-up of six patients. Dtsch Med Wochenschr 2002;127:1876-1880
    • (2002) Dtsch Med Wochenschr , vol.127 , pp. 1876-1880
    • Lamprecht, P.1    Arbach, O.2    Voswinkel, J.3
  • 116
    • 0036796830 scopus 로고    scopus 로고
    • Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitidis: An open pilot study on 10 patients
    • Bartolucci P, Ramanoelina J, Cohen P, et al. Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients. Rheumatology (Oxford) 2002;41:1126-1132 (Pubitemid 35203539)
    • (2002) Rheumatology , vol.41 , Issue.10 , pp. 1126-1132
    • Bartolucci, P.1    Ramanoelina, J.2    Cohen, P.3    Mahr, A.4    Godmer, P.5    Le Hello, C.6    Guillevin, L.7
  • 117
    • 27444446509 scopus 로고    scopus 로고
    • Current state of tumour necrosis factor alpha blockade in Wegener's granulomatosis
    • DOI 10.1136/ard.2005.042416
    • Mukhtyar C, Luqmani R. Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis. Ann Rheum Dis 2005;64:iv31-36 (Pubitemid 41532014)
    • (2005) Annals of the Rheumatic Diseases , vol.64 , Issue.SUPPL. 4
    • Mukhtyar, C.1    Luqmani, R.2
  • 119
    • 33750214245 scopus 로고    scopus 로고
    • Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab
    • DOI 10.1093/rheumatology/kel098
    • Stasi R, Stipa E, Del Poeta G, et al. Observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology (Oxford) 2006;45:1432-1436 (Pubitemid 44605482)
    • (2006) Rheumatology , vol.45 , Issue.11 , pp. 1432-1436
    • Stasi, R.1    Stipa, E.2    Del Poeta, G.3    Amadori, S.4    Newland, A.C.5    Provan, D.6
  • 120
  • 121
    • 20144368363 scopus 로고    scopus 로고
    • Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab
    • DOI 10.1111/j.1365-2796.2005.01494.x
    • Eriksson P. Nine patients with anti-neutrophil cytoplasmic antibody positive vasculitis successfully treated with rituximab. J Intern Med 2005;257:540-548 (Pubitemid 40776514)
    • (2005) Journal of Internal Medicine , vol.257 , Issue.6 , pp. 540-548
    • Eriksson, P.1
  • 122
    • 62549152024 scopus 로고    scopus 로고
    • Deoxyspergualin in relapsing and refractory Wegener's granulomatosis
    • Epub ahead of print
    • Flossmann O, Baslund B, Bruchfeld A, et al. Deoxyspergualin in relapsing and refractory Wegener's granulomatosis. Ann Rheum Dis 2008 [Epub ahead of print]
    • (2008) Ann Rheum Dis
    • Flossmann, O.1    Baslund, B.2    Bruchfeld, A.3
  • 123
    • 1642545105 scopus 로고    scopus 로고
    • Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): An open study in 15 patients
    • DOI 10.1111/j.1523-1755.2004.00534.x
    • Schmitt WH, Hagen EC, Neumann I, et al. Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 2004;65:1440-1448 (Pubitemid 38406986)
    • (2004) Kidney International , vol.65 , Issue.4 , pp. 1440-1448
    • Schmitt, W.H.1    Hagen, E.C.2    Neumann, I.3    Nowack, R.4    Flores-Suarez, L.F.5    Van Der Woude, F.J.6
  • 125
    • 49149124643 scopus 로고    scopus 로고
    • Apparent response to anti-IgE therapy in two patients with refractory 'forme fruste' of Churg-Strauss syndrome
    • Pabst S, Tiyerili V, Grohé C. Apparent response to anti-IgE therapy in two patients with refractory 'forme fruste' of Churg-Strauss syndrome. Thorax 2008;63(8):747-748
    • (2008) Thorax , vol.63 , Issue.8 , pp. 747-748
    • Pabst, S.1    Tiyerili, V.2    Grohé, C.3
  • 126
    • 52049098285 scopus 로고    scopus 로고
    • A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome
    • Metzler C, Schnabel A, Gross WL, Hellmich B. A phase II study of interferon-alpha for the treatment of refractory Churg-Strauss syndrome. Clin Exp Rheumatol 2008;26(3 Suppl 49):S35-40
    • (2008) Clin Exp Rheumatol , vol.26 , Issue.3 SUPPL. 49
    • Metzler, C.1    Schnabel, A.2    Gross, W.L.3    Hellmich, B.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.